Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2000
11/22/2000EP1053235A1 Oxazole derivatives as serotonin-1a receptor agonists
11/22/2000EP1053228A1 Perylene imide monocarboxylic acids as colorants
11/22/2000EP1053226A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000CN1274284A Methods of modulating serine/threnoine protein kinase function with 5-azaquinoxaline-based compounds
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/22/2000CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same
11/21/2000US6150526 Piperidine derivative having renin inhibiting activity
11/21/2000US6150525 Multistage process for preparation by condensation 1-hydroxy 5-(dimethylaminomethyleneimino)pyrrolo(3,2-b)pyridine with 1-methyl-4-piperidinone in the presence of base optionally deprotect and hydrogenation
11/21/2000US6150523 Process for preparing imidazoquinolinamines
11/21/2000US6150414 Inhibiting a virus causing infection (such as hiv) by administering the compound 1,3,4,6-tetrahydroxy-7,16-dioxo-7,16-dihydro-dibenzo(a,o)perylene
11/21/2000US6150379 Compounds and compositions as anticoagulants
11/21/2000US6150376 Bi- and tri-cyclic aza compounds and their uses
11/21/2000US6150359 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
11/21/2000US6150343 10-hydroxy-7-substituted silylcamptothecin derivative is used as anticarcinogenic and antitumor agent
11/21/2000CA2037608C Process for the preparation of castanospermine
11/21/2000CA2019812C Novel 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
11/16/2000WO2000068232A1 Cucurbiturils and method for synthesis
11/16/2000WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof
11/16/2000WO2000068204A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
11/16/2000WO2000068202A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
11/16/2000WO2000068197A1 3a,4,5,9b-TETRAHYDRO-1H-BENZ[e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000034437A3 Inhibitors of prenyl-protein transferase
11/16/2000WO2000027846A3 Crf receptor antagonists and methods relating thereto
11/16/2000WO2000020358A3 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
11/16/2000WO2000006525A3 Synthesis of combinatorial libraries of compounds reminiscent of natural products
11/16/2000DE10021266A1 Hergestellte Artikel mit Phosphodiesterase-Inhibitor Produced with Article phosphodiesterase inhibitor
11/16/2000CA2373076A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
11/16/2000CA2373035A1 3a,4,5,9b-tetrahydro-1h-benz¬e|indol-2-yl amine-derived neuropeptide y receptors ligands useful in the treatment of obesity and other disorders
11/16/2000CA2371472A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
11/15/2000EP1052255A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics.
11/15/2000EP1052254A1 Nitrogenous heterocyclic derivatives and medicine thereof
11/15/2000EP1051415A1 Benzamide derivatives as vasopressin antagonists
11/15/2000EP1051176A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/15/2000CN1058495C Polycyclic systems compound and derivatives thereof as neurotransmitter release enhancers useful in the treatment of cognitive disordes and medicine containing them and its use
11/14/2000US6147089 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/14/2000US6147088 Antagonists of gonadotropin releasing hormone
11/14/2000US6147087 Use of 1,2-Bridged 1,4-dihydropyridines as medicaments
11/14/2000US6147085 Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147071 Tachykinin receptor antagonist
11/14/2000CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives
11/09/2000WO2000066586A1 Heteroaryl diazabicycloalkanes, their preparation and use
11/09/2000WO2000066583A1 Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
11/09/2000WO2000066582A1 Substituted pyrazole derivative
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066120A1 Novel catechols as antimicrobial agents
11/09/2000WO2000066119A1 Novel prolines as antimicrobial agents
11/09/2000WO2000066114A1 Treatment of female arousal disorder
11/09/2000WO2000066099A2 Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
11/09/2000WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000DE19921424A1 Substituierte Benzoylketone Substituted benzoyl ketones
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000DE19920352A1 Substituiertes Pyrazolderivat Substituted pyrazole derivative
11/09/2000CA2372176A1 Novel prolines as antimicrobial agents
11/09/2000CA2372079A1 Novel catechols as antimicrobial agents
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2365782A1 Treatment of female arousal disorder
11/09/2000CA2365258A1 Heteroaryl diazabicycloalkanes, their preparation and use
11/09/2000CA2365212A1 Substituted 3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
11/08/2000EP1050535A1 Fused pyrazine compounds
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP0656002B1 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/07/2000US6143905 1,7-diaroxy- or 1,7-arylthio-substituted perylene-3,4,9,10-tetracarboxylic acids, their dianhydrides and diimides
11/07/2000US6143894 Preparation of [1S-[1A,2B,3B,4A(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl propyl]amino] -3H-imidazo[4,5-B]pyridin-3-yl]-N-ethyl-2,3-dihydroxycyclopentanecarboxa mide
11/07/2000US6143890 Reacting perylene tetracarboxylic-3,4-monoanhydride derivatives with a disubstituted hydrazine
11/07/2000US6143767 Piperidinylamino tricyclic compounds as substance P antagonists
11/07/2000US6143762 Tetrahydroisoquinoline derivatives and their pharmaceutical use
11/07/2000US6143760 Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
11/07/2000US6143759 Tetrazoles
11/07/2000US6143757 Chemical compounds
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143743 Treatment of nervous system disorders
11/07/2000CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them
11/07/2000CA2022488C 2,3-dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments
11/02/2000WO2000064987A1 Novel amidopyrylium fluorescence dyes
11/02/2000WO2000064986A1 Novel carbopyronine fluorescence dyes
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064898A1 Azaindole derivatives for the treatment of depression
11/02/2000WO2000064897A1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament
11/02/2000WO2000064491A1 4-fluoroalkyl-3-halophenyl nortropanes
11/02/2000WO2000064478A1 Preventives/remedies for liver diseases
11/02/2000WO2000064449A1 Thrombin inhibitors
11/02/2000WO2000040584A3 Process for preparing n6-substituted deaza-adenosine derivatives
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000037469B1 Process for preparing n6-substituted deaza-adenosine derivatives
11/02/2000EP1048667A1 Process for preparing 8-cyclopentyl-6-ethyl-3-(substituted)-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-as-indacenes and intermediates useful therein
11/02/2000EP1048666A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT
11/02/2000EP1048651A1 Nitrogen-containing tetracyclic compounds
11/02/2000EP1047698A1 Piperazino derivatives as neurokinin antagonists
11/02/2000EP1047696A1 Synthesis of long-wavelength absorbing photosensitizers
11/02/2000EP1047695A1 Novel bispidine antiarrhythmic compounds
11/02/2000EP1047694A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
11/02/2000EP1047691A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 646